Algal Omega-3: The Vegan EPA+DHA Source, What Trials Show

By Erin Rose · Updated July 19, 2026 · Methodology

Educational overview — not medical advice. Algal omega-3 is not a treatment for any diagnosed condition, and no algal-oil product has been tested in a hard cardiovascular-outcome trial. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Ranked by disclosed EPA+DHA and cost per gram, never commissions.

Start here

What algal omega-3 is, and the four threads that hold up

Algal oil is EPA and/or DHA extracted directly from cultivated marine microalgae (commonly Schizochytrium or Ulkenia species) rather than from fish tissue — the same biosynthetic origin fish rely on, just without the fish. Doughman 2007, a narrative review, frames this plainly: algae synthesize EPA/DHA; fish accumulate it up the food chain. That's a different picture than flaxseed, chia, or walnut oil, which deliver ALA — a plant omega-3 that converts poorly to EPA/DHA in the human body (Santos 2020). Algal oil delivers preformed EPA/DHA directly, which is why it can be compared to fish oil at all.

Four threads of verified human trial data run through this evidence base. First, bioequivalence: Arterburn 2008 (n=32, 2 weeks) gave healthy adults 600mg DHA/day from either algal-oil capsules or assayed portions of cooked salmon — DHA rose ~80% in plasma phospholipids and ~25% in erythrocytes in both groups, statistically equivalent by the authors' own bioequivalence analysis. A companion trial, Arterburn 2007 (n=12/group, 28 days), dose-ranged two algal DHA oil strains against a DHA-fortified food and found linear, dose-dependent, statistically equivalent uptake across all three delivery forms. Both trials are affiliated with Martek Biosciences, the DHASCO algal-oil manufacturer — a real conflict of interest, disclosed here every time these trials are cited. Second, blood-lipid measures: Geppert 2006 (n=114 vegetarians, 8 weeks, EPA-free algal DHA) and Maki 2014 (n=93 adults, a 2.4g/day algal DHA+EPA blend against a 2.0g/day fish-oil comparator) measured triglycerides. Third, and this is the honesty thread that must travel with the second: LDL-cholesterol rose in nearly every algal-DHA trial. Bernstein 2012, a meta-analysis pooling 11 RCTs (n=485), reported changes in triglycerides, HDL-C, and LDL-C (a pooled +0.23 mmol/L, roughly +9mg/dL, for LDL-C) — Harvard-affiliated authors with no apparent industry association. Fourth, the vegan/vegetarian-population evidence: Conquer & Holub 1996 (n=24 vegetarians, DHA-only oil) found serum DHA rose 246% over 6 weeks, and Sarter 2015 found a low-baseline subgroup of vegans raised their omega-3 index from 3.1% to 4.8% on a modest 254mg/day dose — see this site's omega-3 index test page for how the index is measured.

How to read the research

On raising blood DHA, the trials agree. Algal oil has never been directly tested in a cardiovascular-outcome trial, and that distinction has to stay explicit every time this evidence gets summarized. The bioequivalence data (Arterburn 2008, 2007) is the closest thing to a direct "vs. real fish" comparison in the human literature. The blood-lipid trials (Geppert, Maki) measured triglycerides and reported different results by marker. Every landmark cardiovascular-outcome trial that news coverage cites for omega-3s — VITAL, ASCEND, REDUCE-IT, GISSI-Prevenzione — dosed fish-derived EPA/DHA, never algal oil. Algal oil's case is bioequivalence plus biomarker measurement, extrapolated from the premise that once DHA/EPA is in the bloodstream, the body doesn't know which organism made it. That premise is biologically reasonable, but it is an extrapolation, not an outcome finding. This page does not say algal oil treats or prevents any condition.

The buying and safety problem

Shop by mg AND ratio — this page's version of krill oil's "shop by mg, not softgel weight" rule, one layer deeper. Of the 5 verified products in this comparison, all disclose a total EPA+DHA (or DHA-alone) figure, so a cost-per-gram comparison is possible for every one of them — but only Nordic Naturals discloses its individual EPA:DHA split, and Garden of Life is DHA-only with zero disclosed EPA, a real ranking flag, not a technicality — see the full breakdown. On safety: serious adverse events were not reported across the trials reviewed here, including Arterburn 2007's 28-day dose-ranging trial up to 1,000mg DHA/day and Sanders 2006's 4g/day oil trial. LDL-C rise is the most consistent lipid finding in this evidence base — a modest bump (Bernstein's pooled estimate: roughly +9mg/dL) that should be stated plainly. The standard omega-3 caveat applies: talk to a clinician before starting if you take warfarin, other anticoagulants, or high-dose aspirin/NSAIDs. Algal oil is not fish- or shellfish-derived (see krill oil and cod liver oil, the other two omega-3 sources on this site). Always check a specific product's label and capsule material.

Frequently asked questions

Related guides

• Krill Oil — the phospholipid-bound marine omega-3 source, and why density usually beats its absorption edge
• Cod Liver Oil — where the vitamin A load, not the omega-3, is the real dosing constraint
• Omega-3 Index Test — how the omega-3 index is measured

Sources